Soleno Therapeutics

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell SLNO and other ETFs, options, and stocks.

About SLNO

Soleno Therapeutics, Inc. engages in the development and commercialization of novel therapeutics for the treatment of rare diseases. The firm focuses on the treatment of metabolic and neurobehavioral disorder. 

CEO
Anish Bhatnagar
CEOAnish Bhatnagar
Employees
31
Employees31
Headquarters
Redwood City, California
HeadquartersRedwood City, California
Founded
1999
Founded1999
Employees
31
Employees31

SLNO Key Statistics

Market cap
8.20M
Market cap8.20M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
149.25K
Average volume149.25K
High today
$1.08
High today$1.08
Low today
$1.00
Low today$1.00
Open price
$1.03
Open price$1.03
Volume
27.91K
Volume27.91K
52 Week high
$10.05
52 Week high$10.05
52 Week low
$0.90
52 Week low$0.90

SLNO Earnings

-$2.10
-$1.40
-$0.70
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 30, After Hours
ActualExpected Mar 30, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.